HROW:NASDAQ
Harrow Inc
30,62 $
arrow_upward
+0,89%(+0,27) 1 d.
30,62 $
0,00% (0,00)
bedtimePēctirdzniecības
Slēgts: 7. okt., 16:00:01 GMT-4 · USD
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: HROW…
Atvērt
30,09 $
Augsta
31,11 $
Zema
29,90 $
Tirgus kapitalizācija
1,15 mljrd.
Vid. apjoms
542,32 tūkst.
Apjoms
402,12 tūkst.
Augstākā 52 ned.
54,85 $
Zemākā 52 ned.
28,54 $
Peļņa uz vienu akciju
-1,00 $
Beta
0,19
Apgrozībā esošās akcijas
37,49 milj.
Darbinieku skaits
373
Atvērt
30,09 $
Augsta
31,11 $
Zema
29,90 $
Tirgus kapitalizācija
1,15 mljrd.
Vid. apjoms
542,32 tūkst.
Apjoms
402,12 tūkst.
Augstākā 52 ned.
54,85 $
Zemākā 52 ned.
28,54 $
Peļņa uz vienu akciju
-1,00 $
Beta
0,19
Apgrozībā esošās akcijas
37,49 milj.
Darbinieku skaits
373
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
The Business Journals
·
pirms 2 dienām
Harrow invests $30 million in new pharmaceutical as it builds portfolio
AD HOC NEWS
·
pirms 2 dienām
Harrow Health stock gets TYRVAYA after USD 30 million deal
TipRanks
·
pirms 2 dienām
Harrow Closes TYRVAYA Acquisition, Expanding Dry Eye Portfolio
Profils
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company. In 2017, Harrow started and funded Eton Pharmaceuticals with a $20 million Series A financing, and Eton is now a publicly traded company. In 2017, Harrow started Surface Pharmaceuticals, hiring Dr. Kamran Hosseini to be its chief executive officer. Surface was funded with a $20 million Series A financing with Flying L Partners leading the round. In 2018, Harrow started Melt Pharmaceuticals and announced an $11 million Series A financing.
In 2019, Harrow hired founder and former CEO of Doxy.me, Drew Livingston, as its chief innovation officer. Livingston is the senior executive of Harrow's Visionology.com telemedicine subsidiary. Wikipedia
Par “Harrow Inc”
ĢenerāldirektorsMark L. Baum Esq.
Darbinieki373
Dibināšanas datums2012
Galvenais birojsNešvila, Tenesī, Amerikas Savienotās Valstis
Sektors-
Tīmekļa vietneharrow.com